default author photo

Anchalee Avihingsanon

Thai Red Cross AIDS Research Centre, Bangkok

Thailand

Chulalongkorn University

Bangkok

Bangkok 10330

Thailand

SCHOLARLY PAPERS

2

DOWNLOADS

114

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

Efficacy and Safety of Ravidasvir Plus Sofosbuvir in Chronic Hepatitis C Infected Subjects Without Cirrhosis or with Compensated Cirrhosis: Interim Analysis Results of a Two-Stage, Open-Label, Multicentre, Phase 2/3 Trial

Number of pages: 28 Posted: 08 Dec 2020
Drugs for Neglected Diseases Initiative (DNDi), Selayang Hospital - Department of Hepatology, Ministry of Public Health - Department of Disease Control, Chiang Mai University - PHPT/IRD, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Chiang Mai University - PHPT/IRD, Hospital Ampang - Department of Medicine/Gastroenterology, Hospital Sultanah Bahiyah - Department of Medicine/Gastroenterology, Hospital Selayang - Department of Hepatology, Hospital Tengku Ampuan Afzan - Department of Medicine/Gastroenterology, University of Malaya (UM) - Gastroenterology and Hepatology Unit, Hospital Sungai Buloh - Department of Medicine/Infectious Disease, Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital, Nakornping Hospital, Thai Red Cross AIDS Research Centre, Bangkok, Bamrasnaradura Infectious Diseases Institute, Geneva University Hospitals and Faculty of Medicine - Laboratory of Virology, Chiang Mai University - PHPT/IRD, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi) and Ministry of Health Malaysia
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

2.

Drug Susceptibility Testing and Mortality in Patients Treated for Tuberculosis in High-Burden Countries

, Infectious Diseases, Volume 19, Issue 3, P298-307, March 01, 2019, https://doi.org/10.1016/S1473-3099(18)30673-X
Number of pages: 39 Posted: 07 Sep 2018
University of Bern - Institute of Social and Preventive Medicine, University of Bern - Institute of Social and Preventive Medicine, University of Bern - Institute of Social and Preventive Medicine, University of Basel - Swiss Tropical and Public Health Institute, University of Zurich, Centre de Prise en Charge de Recherche et de Formation, Yopougon, University of Bordeaux, Ohio State University (OSU) - Division of Epidemiology, Moi University, Moi University, University of Cape Town (UCT) - Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town (UCT), University of Cape Town (UCT), - Institute of Human Virology, - Institute of Human Virology, Universidad Peruana Cayetano Heredia, Thai Red Cross AIDS Research Centre, Bangkok, Chulalongkorn University, University of Basel - Swiss Tropical and Public Health Institute, University of Zurich, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), University of Basel - Swiss Tropical and Public Health Institute, University of Zurich and University of Bern - Institute of Social and Preventive Medicine
Downloads 47 (1,097,529)
Citation 1

Abstract:

Loading...

Tuberculosis, Drug Resistance, MDR-TB, XDR-TB, Mortality, Treatment Success, Low- and Middle-Income Countries